Time is on our side — rethinking the concept of time to treatment for prostate cancer

Hanna, T. P. et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 371, m4087 (2020).

Article  PubMed  Google Scholar 

Cone, E. B. et al. Assessment of time-to-treatment initiation and survival in a cohort of patients with common cancers. JAMA Netw. Open 3, e2030072 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Neal, R. D. et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br. J. Cancer 112, S92–S107 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Robinson, H. S., Lee, S. S., Barocas, D. A. & Tosoian, J. J. Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-024-00840-0 (2024).

Article  PubMed  Google Scholar 

Laukhtina, E. et al. Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review. World J. Urol. 39, 4085–4099 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Nguyen, D.-D. et al. Systematic review of time to definitive treatment for intermediate risk and high risk prostate cancer: are delays associated with worse outcomes? J. Urol. 205, 1263–1274 (2021).

Article  PubMed  Google Scholar 

Mohamad, O. et al. Delayed definitive management of localized prostate cancer: what do we know? Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-024-00876-2 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Fanshawe, J. B. et al. Decision regret in patients with localised prostate cancer: a systematic review and meta-analysis. Eur. Urol. Oncol. 6, 456–466 (2023).

Article  PubMed  Google Scholar 

Jones, R. A. Decisional regret among men with prostate cancer: what is involved? JAMA Oncol. 8, 59–60 (2022).

Article  PubMed  Google Scholar 

Martínez-González, N. A. et al. Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials. Swiss Med. Wkly 148, w14584 (2018).

PubMed  Google Scholar 

Comments (0)

No login
gif